COLLEGIUM PHARMACEUTICAL, INC financial data

Symbol
COLL on Nasdaq
Location
Stoughton, MA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 26 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 129% % 23%
Quick Ratio 8.4% % 18%
Debt-to-equity 522% % 3.1%
Return On Equity 24% % -21%
Return On Assets 3.9% % -23%
Operating Margin 23% % -14%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 31,753,211 shares 0.85%
Common Stock, Shares, Outstanding 31,707,608 shares 0.85%
Entity Public Float $926,400,000 USD -10%
Common Stock, Value, Issued $41,000 USD 2.5%
Weighted Average Number of Shares Outstanding, Basic 31,652,987 shares -1.3%
Weighted Average Number of Shares Outstanding, Diluted 40,076,457 shares -0.08%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $780,567,000 USD 24%
Operating Income (Loss) $179,636,000 USD 5.7%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $92,619,000 USD -6%
Income Tax Expense (Benefit) $29,749,000 USD 1.3%
Net Income (Loss) Attributable to Parent $62,870,000 USD -9.1%
Earnings Per Share, Basic 2 USD/shares -6.5%
Earnings Per Share, Diluted 1.71 USD/shares -8.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $231,252,000 USD 228%
Marketable Securities, Current $155,427,000 USD 69%
Accounts Receivable, after Allowance for Credit Loss, Current $211,328,000 USD -7.5%
Inventory, Net $40,912,000 USD 15%
Other Assets, Current $3,239,000 USD 18%
Assets, Current $691,411,000 USD 43%
Deferred Income Tax Assets, Net $112,539,000 USD 15%
Property, Plant and Equipment, Net $12,013,000 USD -16%
Operating Lease, Right-of-Use Asset $4,187,000 USD -28%
Intangible Assets, Net (Excluding Goodwill) $669,510,000 USD -25%
Goodwill $145,925,000 USD -10%
Other Assets, Noncurrent $20,193,000 USD 141%
Assets $1,656,834,000 USD -0.41%
Accounts Payable, Current $10,659,000 USD 171%
Employee-related Liabilities, Current $3,382,000 USD -26%
Accrued Liabilities, Current $62,464,000 USD -13%
Contract with Customer, Liability, Current $667,000 USD
Liabilities, Current $440,028,000 USD -14%
Contract with Customer, Liability, Noncurrent $9,111,000 USD -8.9%
Deferred Income Tax Liabilities, Net $29,141,000 USD -46%
Operating Lease, Liability, Noncurrent $4,132,000 USD -25%
Liabilities $1,355,159,000 USD -5.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax $319,000 USD 480%
Retained Earnings (Accumulated Deficit) $101,129,000 USD 38%
Stockholders' Equity Attributable to Parent $301,675,000 USD 32%
Liabilities and Equity $1,656,834,000 USD -0.41%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $55,398,000 USD -11%
Net Cash Provided by (Used in) Financing Activities $25,236,000 USD 53%
Net Cash Provided by (Used in) Investing Activities $9,680,000 USD 47%
Common Stock, Shares Authorized 100,000,000 shares 0%
Common Stock, Shares, Issued 40,736,330 shares 2.7%
Common Stock, Par or Stated Value Per Share 0.001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $252,158,000 USD 161%
Interest Paid, Excluding Capitalized Interest, Operating Activities $21,694,000 USD 24%
Deferred Tax Assets, Valuation Allowance $5,289,000 USD -19%
Deferred Tax Assets, Gross $146,969,000 USD -7.4%
Operating Lease, Liability $5,539,000 USD -19%
Depreciation $4,182,000 USD 8.5%
Payments to Acquire Property, Plant, and Equipment $798,000 USD 40%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $63,134,000 USD -8.8%
Lessee, Operating Lease, Liability, to be Paid $6,217,000 USD -21%
Property, Plant and Equipment, Gross $28,555,000 USD 2.5%
Operating Lease, Liability, Current $1,407,000 USD 11%
Lessee, Operating Lease, Liability, to be Paid, Year Two $1,750,000 USD 1.3%
Lessee, Operating Lease, Liability, to be Paid, Year One $1,728,000 USD 2.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.066 pure 0%
Deferred Income Tax Expense (Benefit) $539,000 USD 88%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $678,000 USD -38%
Lessee, Operating Lease, Liability, to be Paid, Year Three $1,572,000 USD -10%
Deferred Tax Assets, Operating Loss Carryforwards $17,954,000 USD -32%
Preferred Stock, Shares Authorized 5,000,000 shares 0%
Unrecognized Tax Benefits $10,500,000 USD -7.1%
Lessee, Operating Lease, Liability, to be Paid, Year Four $1,167,000 USD -26%
Additional Paid in Capital $624,954,000 USD 5.9%
Amortization of Intangible Assets $165,304,000 USD 13%
Deferred Tax Assets, Net of Valuation Allowance $141,680,000 USD -6.9%
Share-based Payment Arrangement, Expense $32,400,000 USD 19%
Interest Expense $79,251,000 USD 0.56%
Preferred Stock, Par or Stated Value Per Share 0.001 USD/shares 0%